Joint Filing Agreement
EXHIBIT A
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary shares, par value $0.001 per share, of ShangPharma Corporation, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
[Remainder of this page has been left intentionally blank.]
SIGNATURE
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of February 9, 2011.
Xxxxxxx Xxx Xxx | /s/ Xxxxxxx Xin Xxx | |
Xxxxxxx Xxx Xxx | ||
The Xxxxxxx Xxx Xxx Irrevocable Qualified Annuity Trust | ||
/s/ Xxxxxxx Xxxxxx | ||
Name: Xxxxxxx Xxxxxx | ||
Title: Vice President – Trust Officer | ||
On behalf of Citicorp Trust, N.A., as trustee of The Xxxxxxx Xxx Xxx Irrevocable Qualified Annuity Trust | ||
Hui Family Trust | /s/ Xxxxxx Xxxxxxx | |
Name: Xxxxxx Xxxxxxx | ||
Title: Authorized Signatory | ||
On behalf of Managecorp Limited of Portcullis TrustNet Xxxxxxxx, as trustee of Hui Family Trust | ||
ChemPartner Investment Holdings Limited | /s/ Xxxxxxx Xxx Xxx | |
Name: Xxxxxxx Xxx Xxx | ||
Title: Director | ||
ChemPartner Investment Holdings Limited | /s/ Xxxxxxx Xxx Xxx | |
Name: Xxxxxxx Xxx Xxx | ||
Title: Director |